Momentum Biotechnologies Welcomes Harvard Medical School Professor Dr. Ying Lu to its Scientific Advisory Board

BILLERICA, Mass., Aug. 10, 2023 /PRNewswire/ — Momentum Biotechnologies (“Momentum” or the “Company”), a leading contract research organization (“CRO”) specializing in mass spectrometry-based native detection technologies, is pleased to announce the appointment of Harvard Medical School…

Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.